Artgen Biotech PJSC (MOEX:ISKJ)

Artgen Biotech PJSC Revenue

In the year 2025, Artgen Biotech PJSC had annual revenue of 1.72B RUB with 12.80% growth. Artgen Biotech PJSC had revenue of 838.87M in the half year ending June 30, 2025, with 35.06% growth.

• Revenue: 1.72B
• Revenue Growth: +12.80%
• P/S Ratio: 2.50
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.72B	194.69M	12.80%
Dec 31, 2024	1.52B	152.94M	11.18%
Dec 31, 2023	1.37B	231.65M	20.38%
Dec 31, 2022	1.14B	-43.89M	-3.72%
Dec 31, 2021	1.18B	96.77M	8.93%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 15, 2026

Data Sources Report a data error